The incidence of coronavirus infections continues to increase in Germany, and according to the records of the Robert Koch Institute (RKI), delivered this Sunday (01.30.2022), the figure reached a new record of 1,156.8. This number reflects the number of new positives for SARS-CoV.2 registered in seven days in the European country, and has been steadily growing for weeks.
To graph the force with which this figure has increased, it can be compared with the figure for Saturday (1,127.7), last Sunday (806.8) and a month ago (207.4). In the past 24 hours, the authorities officially registered a total of 118,970 new infections, a figure significantly higher than that of Sunday, January 23, when 85,440 infections were reported.
Experts assume that the real figures are always much higher than those reported, among other reasons because many infections (especially the less serious ones) are not reported, testing capacity is overstretched in various regions of the country and those in charge themselves are unable to notify all infections detected due to work overload.
every nine minutes
At the national level, there were also 59 new deaths related to covid-19, bringing the total number of deaths since March 2020 as a result of the pandemic to 117,725. This implies that since the health crisis broke out, one person has died of covid in Germany every nine minutes. It is worth noting, however, that the number of deaths has decreased markedly since the introduction of vaccines.
For the RKI, 9,737,215 people have contracted the coronavirus, this is about 12 percent of the population of Germany. Of these, 7,564,200 are considered recovered by the authorities. The virus reproduction rate is 1.17 (100 people infect 117) and 75.7 percent of the German population has received at least one dose of the vaccines authorized in Europe to deal with the pandemic.
The vaccines that promise to defeat the coronavirus
Sputnik V, Instituto Gamaleya
The “Russian vaccine” aroused initial mistrust, but it has established itself as an option for some twenty countries, including Argentina, Bolivia and Venezuela. Doubts arose due to its rapid approval, in August 2020, without having finished the trials. However, later studies give high efficacy to this preparation, which uses adenoviral vectors to provoke immunity.
–
–
The vaccines that promise to defeat the coronavirus
BNT162b2, BioNTech/Pfizer
The vaccine from the German firm BioNTech uses a previously unpublished technology: mRNA covered by lipids. Explained simply, the vaccine “mimics” the form of SARS-CoV-2, causing the body’s response. In trials it showed high efficacy, which has been replicated in real conditions. The firm Pfizer acts in the alliance as a manufacturing partner. It is used in twenty countries.
–
–
The vaccines that promise to defeat the coronavirus
mRNA-1273, Modern
The vaccine developed by the National Institute of Allergy and Infectious Diseases, the Biomedical Advanced Research and Development Authority (BARDA) and the firm Moderna uses technology similar to that of BioNTech. In trials, it showed an efficacy close to 95 percent. Unlike BioNTech, this formula can be stored at -20 degrees. It is used in the US and the European Union.
–
–
The vaccines that promise to defeat the coronavirus
AZD1222, Oxford-AstraZeneca
This vaccine developed by British and Swedish experts uses a modified chimpanzee adenovirus as a vector. The trials took place in the UK, Brazil, South Africa, Japan and India, and were interrupted a couple of times due to suspicious deaths. However, its safety and efficacy ranging from 60 to 90 percent have been confirmed. It is used in Brazil, the EU and the United Kingdom.
–
–
The vaccines that promise to defeat the coronavirus
Ad5-nCoV, Cansino Biologics
This Chinese firm’s vaccine uses the common cold adenovirus to introduce an inactivated SARS-CoV-2 protein into the human body, causing an immune response. It has been used in China to inoculate soldiers of the People’s Army, and trials have been carried out in Russia, Pakistan, Mexico, Chile and Argentina. It is currently used in Mexico, Malaysia and Indonesia. Use only one dose.
–
–
The vaccines that promise to defeat the coronavirus
CoronaVac, Sinovac Biotech
Like many vaccines that use inactivated viruses, this formula uses SARS-CoV-2 particles obtained in cultures and inactivated before being injected into the body. The presence of these viruses provokes the immune reaction and prevents the disease from developing. Tested in Brazil, Indonesia, Chile and Turkey, it shows an effectiveness greater than 60 percent.
–
–
The vaccines that promise to defeat the coronavirus
BBV152, Bharat Biotech
Also using inactivated virus, this vaccine developed by Bharat and the Indian Council of Medical Research is known as Covaxin, and has shown 81 percent efficacy in clinical trials. At the time, it sparked controversy for having been inoculated into medical workers when the formula was still in phase I clinical trials. India is now seeking approval in other markets.
–
–
The vaccines that promise to defeat the coronavirus
BBIBP-CorV, Sinopharm
With trials in Argentina, Peru, the United Arab Emirates and other states, this Chinese inactivated virus vaccine has already been approved in Middle Eastern countries. According to studies, it would be 86 percent effective. Sinopharm is in the eye of controversy in Peru for having sent “courtesy vaccines” for politicians and for having donated thousands of dollars to the government.
–
–
The vaccines that promise to defeat the coronavirus
Ad26.COV2.S, Johnson & Johnson
Along with CanSino, it is the only single-dose vaccine to date. It is developed by the Belgian firm Janssen Pharmaceutica, a subsidiary of the American Johnson & Johnson. It can be stored in a normal refrigerator and has shown an efficiency greater than 66 percent. It uses a non-replicative viral vector derived from human adenovirus A26.
